Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.001
-
Shares outstanding
-
303M
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
737K
-
Shares change
-
-299K
-
Total reported value, excl. options
-
$7.23M
-
Value change
-
-$2.91M
-
Number of buys
-
1
-
Number of sells
-
-3
-
Price
-
$9.81
Significant Holders of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB) as of Q4 2023
4 filings reported holding PACB - PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 as of Q4 2023.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. - Common Stock, par value $0.001 (PACB) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 737K shares
of 303M outstanding shares and own 0.24% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (34.5M shares), VANGUARD GROUP INC (26.8M shares), BlackRock Inc. (24.6M shares), Madrone Advisors, LLC (17.6M shares), Sumitomo Mitsui Trust Holdings, Inc. (13.2M shares), Nikko Asset Management Americas, Inc. (13.2M shares), MORGAN STANLEY (11.1M shares), Jackson Square Partners, LLC (9.7M shares), T. Rowe Price Investment Management, Inc. (7.75M shares), and Bellevue Group AG (7.32M shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.